New talk therapy aims to ease PTSD without reliving trauma

NCT ID NCT07351305

Recruiting now Symptom relief Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of talk therapy for veterans and service members who have both PTSD and a mild or moderate traumatic brain injury. The therapy focuses on relaxation, stress management, and problem solving instead of asking patients to relive their trauma. The goal is to see if this approach can reduce PTSD symptoms. The study plans to enroll 30 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Non-Trauma Treatment for TBI and PTSD (T3 PTSD) - behavioral therapy
What this could lead to: If it works, this could provide a safe, effective PTSD treatment option for veterans with brain injuries who cannot tolerate trauma-focused therapy.
What could go wrong: This is a very small early study with only 30 participants, so results may not apply to everyone. The therapy may not reduce PTSD symptoms significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MTBI - MILD TRAUMATIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic post-traumatic stress disorder traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MTBI - MILD TRAUMATIC BRAIN INJURY POST-TRAUMATIC STRESS DISORDER PTSD TRAUMATIC BRAIN INJURY

Contacts and locations

Locations

Carl R Darnall Army Medical Center
RECRUITING

Fort Hood, Texas, 76544, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.